Table 1.
Subject characteristics.
| Parameter | HCM Patients | Healthy Controls | P Value |
|---|---|---|---|
| n | 6 | 6 | |
| Sex (male/female) | 4/2 | 4/2 | |
| Age, y | 52.7 ± 17.5 | 50 ± 12.4 | 0.77 |
| Height, cm | 170 ± 10 | 172 ± 8 | 0.71 |
| Weight, kg | 73.12 ± 9.6 | 71.5 ± 14.1 | 0.82 |
| BMI, kg/m2 | 25.19 ± 1.9 | 23.9 ± 2.9 | 0.39 |
| BSA, m2 | 1.84 ± 0.18 | 1.84 ± 0.21 | 0.97 |
| Systolic blood pressure, mmHG | 142.3 ± 22.8 | 135.5 ± 14.9 | 0.56 |
| Diastolic blood pressure, mmHG | 85.8 ± 17.5 | 86.3 ± 13.6 | 0.96 |
| Heart rate, min−1 | 65.17 ± 10.83 | 71.7 ± 9.8 | 0.30 |
| Mean end-systolic septal wall thickness, mm | 16.6 ± 1.8 | 9.8 ± 1.4 | 0.001* |
| Mean end-diastolic septal wall thickness, mm | 13.0 ± 3.1 | 6.2 ± 1.2 | 0.002* |
| Mean T2* averaged across all phases, ms | 17.4 ± 1.4 | 13.7 ± 1.1 | 0.001* |
| Mean end-systolic septal T2*, ms | 17.7 ± 1.2 | 15.0 ± 2.1 | 0.025* |
| Mean end-diastolic septal T2*, ms | 16.2 ± 2.5 | 13.4 ± 1.3 | 0.039* |
| LVEDV, ml | 128.8 ± 33.3 | 121.02 ± 21.88 | 0.64 |
| LVESV, ml | 51.3 ± 20.0 | 49.35 ± 12.96 | 0.85 |
| LVEF | 60.9 ± 8.5 | 59.3 ± 6.3 | 0.47 |
| LV mass, g | 168.9 ± 68.0 | 93.1 ± 17.0 | 0.041* |
| Presence of late gadolinium enhancement | 6/6 | — |
Values are given as mean ± standard deviation. The P value stems from a student’s t-test except for LVEF where it stems from a Mann-Whitney u-test. BMI, body mass index; BSA, body surface area; *P < 0.05.